Benzinga | Dec 16, 2020 12:21PM EST

Morgan Stanley Maintains Equal-Weight on Biohaven Pharmaceutical, Raises Price Target to $73

Morgan Stanley maintains Biohaven Pharmaceutical (NYSE:BHVN) with a Equal-Weight and raises the price target from $63 to $73.